Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Lidocaine for Scleroderma. Randomized Double-Blind Clinical Trial

NCT00740285 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.

NCT NCT00740285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00740285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Lidocaine for Scleroderma. Randomized Double-Blind Clinical Trial
Lead sponsor
Federal University of São Paulo
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 2004
Completion date
April 30, 2007
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scleroderma